BCL2 and acute myeloid leukemia: This metabolic modulation seems important for the antileukemic effects of Bcl-2 inhibition in AML cells that depend on Bcl-2 for survival [88,89], but monocytic AML cells often do not have such a strong dependency on Bcl-2 [7].